The abstract is read at the publisher; the summary is JClub's.
BMP-2-specific affibody–conjugated HA hydrogels formed inside clinically used collagen sponges enhance dose-dependent ectopic mineralization and increase bone volume in critically sized femoral defects.
- Why it matters: Collagen sponge carriers can release BMP-2 in bursts that risk inflammation and ectopic bone, while alternative vehicles may stiffen too much and limit cell infiltration needed for bone formation.
- What they did: The team built a maleimide functionalized, hydrazone crosslinked HA hydrogel with affibody conjugation orthogonal to network formation, varying affibody density independently of crosslinking, then formed it within collagen sponges. In vitro, composites showed minimal swelling and retained more BMP-2 than collagen sponge alone.
- The result: In vivo, affibody-conjugated composites improved ectopic mineralization in a BMP-2 dose-dependent manner, and in critically sized femoral defects both affibody-present and affibody-free composites increased bone volume versus the collagen sponge.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.